What’s Next? Five Things To Look Out For In September
Alvotech Likely To Hear From USFDA On Humira Biosimilar
Executive Summary
In the month ahead, Alvogen’s biosimilars sister company Alvotech is anticipated to receive a USFDA decision on its biosimilar Humira candidate, while Hikma’s management will meet investors to discuss prospects for its Generics business.